UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.
FDA approves UCB's Keppra for treatment of partial onset seizures in infants
- Login or register to post comments
- Feed: Pediatrics News Feed
- Original article